Seres Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $60.7M | $36.1M |
| FY2018 | — | $-48.0M | $85.8M |
| FY2019 | $25.0M | $-48.3M | $65.1M |
| FY2020 | $25.0M | $174.8M | $116.0M |
| FY2021 | $24.1M | $131.5M | $180.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $60.7M | $36.1M |
| FY2018 | — | $-48.0M | $85.8M |
| FY2019 | $25.0M | $-48.3M | $65.1M |
| FY2020 | $25.0M | $174.8M | $116.0M |
| FY2021 | $24.1M | $131.5M | $180.0M |